| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 6e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0006 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.005 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |